Christopher Frampton

Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations

Richard W. Troughton, Christopher Frampton, Timothy G. Yandle et al. · The Lancet · 2000 · 1.4K citations

Neuropeptides, Heart Failure, Cardiovascular Disease +6

A double‐blind, placebo‐controlled study to assess the mitochondria‐targeted antioxidant MitoQ as a disease‐modifying therapy in Parkinson's disease

Barry Snow, Fiona L. Rolfe, Michelle Lockhart et al. · Movement Disorders · 2010 · 588 citations

Mitochondrial Oxidative Stress, Neurodegenerative Diseases, Mitochondrial Function +15

Three Psychotherapies for Anorexia Nervosa: A Randomized, Controlled Trial

Virginia V. W. McIntosh, Jennifer Jordan, Frances A. Carter et al. · American Journal of Psychiatry · 2005 · 484 citations

B-Type Natriuretic Peptides and Ejection Fraction for Prognosis After Myocardial Infarction

Mark Richards, M. Gary Nicholls, Eric A. Espiner et al. · Circulation · 2003 · 438 citations

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin

Mark Richards, Robert N. Doughty, M. Gary Nicholls et al. · Journal of the American College of Cardiology · 2001 · 388 citations

Adrenal Gland, Hypothalamic Peptide, Neuroscience +2